Skip to main content

Advertisement

SpringerLink
Log in

Metabolic syndrome increases oxidative stress but does not influence disability and short-time outcome in acute ischemic stroke patients

  • Original Article
  • Published:
Metabolic Brain Disease Aims and scope Submit manuscript

Abstract

Oxidative stress has been implicated in the pathophysiology of cardiovascular disease and MetS and it may be one of molecular mechanisms involved in stroke. The aims of the present study were to verify differences in oxidative stress markers in acute ischemic stroke patients with and without MetS and to verify whether MetS influences disability and short time outcome of the patients. 148 patients with acute ischemic stroke were divided in two groups: with MetS (n = 92) and without MetS (n = 56). The modified Rankin Scale (mRS) was used for measuring the functional disability after 3-month follow-up. The study assessed the metabolic profile and oxidative stress markers. Stroke patients with MetS had higher levels of lipid hydroperoxides (p < 0.0001) and advanced oxidation protein products (AOPP, p = 0.0302) than those without MetS. Hydroperoxides were directly and independently associated with MetS (OR: 1.000, 95 % IC = 1.000-1.000, p = 0.005). Linear regression demonstrated that AOPP levels (R2 = 0.281, p < 0.0001) and oxidative stress index (OSI, R2 = 0.223, p < 0.0001) were directly associated with triglycerides levels and hydroperoxides levels was also directly associated with glucose levels (R2 = 0.080, p = 0.013. The mRS and short-come outcome did not differ after 3 months in both groups. In conclusion, an increase in oxidative stress markers was shown in acute ischemic stroke patients with MetS and this elevation seems to be involved mainly with changes in lipid profile, but the presence of MetS did not influence short-time disability and survival of the acute ischemic stroke patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  • Adams HP, Bendixen BH, Kappelle LJ et al (1993) Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of org 10172 in acute stroke treatment. Stroke 24:35–41

    Article  PubMed  Google Scholar 

  • Alexandrova ML, Bochev PG (2005) Oxidative stress during the chronic phase after stroke. Free Radic Biol Med 39:297–316

    Article  CAS  PubMed  Google Scholar 

  • Babu MS, Kaul S, Dadheech S, Rajeshwar K, Jyothy A, Munshi A (2013) Serum albumin levels in ischemic stroke and its subtypes: correlation with clinical outcome. Nutrition 29(6):872–875

    Article  CAS  PubMed  Google Scholar 

  • Banks JL, Marotta CA (2007) Outcomes validity and reliability of the modified Rankin scale: implications for stroke clinical trials: a literature review and synthesis. Stroke 38(3):1091–1096

    Article  PubMed  Google Scholar 

  • Bonita R, Beaglehole R (1988) Recovery of motor function after stroke. Stroke 19:1497–1500

    Article  CAS  PubMed  Google Scholar 

  • Cakatay U (2005) Protein oxidation parameters in type 2 diabetic patients with good and poor glycaemic control. Diabetes Metab 31:551–557

    Article  CAS  PubMed  Google Scholar 

  • Casado MF, Cecchini AL, Simão ANC et al (2007) Free radical-mediated pre-hemolytic injury in human red blood cells subjected to lead acetate as evaluated by chemiluminescence. Food Chem Toxicol 45:945–952

    Article  CAS  PubMed  Google Scholar 

  • Chakraborty B, Sishnoi G, Goswami B, Gowda SH, Chowdhury D, Agarwal S (2013) Lipoprotein (a), ferritin, and albumin in acute phase reactions predicts severety and mortality of acute ischemic stroke in North Indian patients. J Stroke Cerebrovasc Dis 22(7):e159–e167

    Article  PubMed  Google Scholar 

  • Chang CY, Lai YC, Cheng TJ, Lau MT, Hu ML (1988) Plasma levels of antioxidant vitamins, selenium, total sulfhydryl groups and oxidative products in ischemic-stroke patients as compared to matched controls in Taiwan. Free Radic Res 28:15--24

  • Cherubini A, Ruggiero C, Polidori MC, Mecocci P (2005) Potential markers of oxidative stress in stroke. Free Radic Biol Med 39:841–852

    Article  CAS  PubMed  Google Scholar 

  • Chiquete E, Ruiz-Sandoval JL, Murilo-Bonilla LM et al (2013) Serum uric acid and outcome after acute ischemic stroke: PREMIER study. Cerebrovasc Dis 35(2):168–174

    Article  CAS  PubMed  Google Scholar 

  • Dichi I, Simão ANC (2012) Metabolic syndrome: new targets for an old problem. Expert Opin Ther Targets 16:1–4

    Article  Google Scholar 

  • Domínguez C, Delgado P, Vilches A et al (2010) Oxidative stress after thrombolysis-induced reperfusion in human stroke. Stroke 41:653–660

    Article  PubMed  Google Scholar 

  • El Kossi MM, Zakhary MM (2000) Oxidative stress in the context of acute cerebrovascular stroke. Stroke 31:1889–1892

    Article  PubMed  Google Scholar 

  • Flecha BG, Llesuy S, Boveris A (1991) Hydroperoxide-initiated chemiluminescence: an assay for oxidative stress in biopsies of heart, liver, and muscle. Free Radic Biol Med 10:93–100

    Article  Google Scholar 

  • Fujita K, Nishizawa H, Funahashi T, Shimomura I, Shimabukuro M (2006) Systemic oxidative stress is associated with visceral fat accumulation and the metabolic syndrome. Circ J 70:1437–1442

    Article  CAS  PubMed  Google Scholar 

  • Gariballa SE, Hutchin TP, Sinclair AJ (2002) Antioxidant capacity after acute ischaemic stroke. QJM 95:685–690

    Article  CAS  PubMed  Google Scholar 

  • Grundy SM, Brewer HB, Cleeman JI et al (2004) Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American heart Association conference on scientific issues related to definition. Arterioscler Thromb Vasc Biol 24:e13–e18

    Article  CAS  PubMed  Google Scholar 

  • Haffner SM, Miettinen H, Stern MP (1997) The homeostasis model in the San Antonio heart study. Diabetes Care 20:1087–1092

    Article  CAS  PubMed  Google Scholar 

  • Hanchaiphiboolkul S, Suwanwela NC, Poungvarin N et al (2013) Risk of metabolic syndrome for stroke is not greater than the sum of its components: Thai epidemiologic stroke (TES) study. J Stroke Cerebrovasc Dis 22:e264–e270

    Article  PubMed  Google Scholar 

  • Hansel B, Giral P, Nobecourt E et al (2004) Metabolic syndrome is associated with elevated oxidative stress and dysfunctional dense high-density lipoprotein particles displaying impaired antioxidative activity. J Clin Endocrinol Metab 89:4963–4971

    Article  CAS  PubMed  Google Scholar 

  • Kalmijn S, Foley D, White L et al (2000) Metabolic cardiovascular syndrome and risk of dementia in Japanese-American elderly men. The Honolulu-Asia aging study. Arterioscler Thromb Vasc Biol 20:2255–2260

    Article  CAS  PubMed  Google Scholar 

  • Katsuki A, Sumida Y, Urakawa H et al (2004) Increased oxidative stress is associated with serum levels of triglyceride, insulin resistance, and hyperinsulinemia in Japanese metabolically obese, normal-weight men. Diabetes Care 27:631–632

    Article  PubMed  Google Scholar 

  • Kondo T, Hirose M, Kageyama K (2009) Roles of oxidative stress and redox regulation in atherosclerosis. J Atheroscler Thromb 16:532–538

    Article  CAS  PubMed  Google Scholar 

  • Lee K-U (2001) Oxidative stress markers in Korean subjects with insulin resistance syndrome. Diabetes Res Clin Pract 54(Suppl2):29–33

    Article  Google Scholar 

  • Manzanero S, Santro T, Arumugam TV (2013) Neuronal oxidative stress in acute ischemic stroke: sources and contribution to cell injury. Neurochem Int 62:712–718

    Article  CAS  PubMed  Google Scholar 

  • Miller M, Stone NJ, Ballantyne C et al (2011) Triglycerides and cardiovascular disease. A Scientific statement from the American Heart Association. Circulation 123:2292–2333

    Article  PubMed  Google Scholar 

  • Mottillo S, Filion KB, Genest J et al (2010) The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. J Am Coll Cardiol 56:1113–1132

    Article  PubMed  Google Scholar 

  • Navab M, Hama SY, Anantharamaiah GM et al (2000) Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: steps 2 and 3. J Lipid Res 41:1495–1508

    CAS  PubMed  Google Scholar 

  • Oh MS, Yu KH, Chu MK, Ma HI, Kim YJ, Kim JY, Lee BC, Mi SO, Kyung-Ho Y, Min-Kyung C, Hyeo-Il M, Yun JK, Joo YK, Byung-Chul L (2011) Long-term prognosis of symptomatic isolated middle cerebral artery disease in Korean stroke patients. BMC Neurol 11:138

    Article  PubMed Central  PubMed  Google Scholar 

  • Osborn MF, Miller CC, Badr A, Zhang J (2014) Metabolic syndrome associated with ischemic stroke among the Mexican Hispanic population in the El Paso/US-Mexico border region. J Stroke Cerebrovasc Dis 23:1477–1484

    Article  PubMed Central  PubMed  Google Scholar 

  • Parreira JS, Kallaur AP, Lehmann MF et al (2015) Tumor necrosis factor beta NcoI polymorphism (rs909253) is associated with inflammatory and metabolic markers in acute ischemic stroke. Metab Brain Dis 30:159–167

    Article  Google Scholar 

  • Pinheiro CHJ, Masi LN, Curi R (2014) Dyslipidemia and atherosclerosis. In: Dichi I, Breganó JW, Simão ANC, Cecchini R (eds) Role of oxidative stress in chronic diseases, 1st edn. Group, CRC Press Taylor & Francis, Boca Raton, p 137, ISBN 9781482216813

    Chapter  Google Scholar 

  • Quinn TJ, Dawson J, Walters MR, Lees KR (2009) Exploring the reliability of the modified Rankin scale. Stroke 40:762–766

    Article  PubMed  Google Scholar 

  • Repetto M, Reides C, Gomez Carretero ML et al (1996) Oxidative stress in blood of HIV infected patients. Clin Chim Acta 255:107–117

    Article  CAS  PubMed  Google Scholar 

  • Reznick AZ, Packer L (1994) Oxidative damage to proteins: spectrophotometric method for carbonyl assay. Methods Enzymol 233:357–363

    Article  CAS  PubMed  Google Scholar 

  • Sabeková K, Boor P, Vlachovicová M et al (2006) Association of metabolic syndrome risk factors with selected markers of oxidative status and microinflammation in healthy omnivores and vegetarians. Mol Nutr Food Res 50:858–868

    Article  Google Scholar 

  • Simão ANC, Dichi JB, Barbosa DS et al (2008) Influence of uric acid and gamma-glutamyltransferase on total antioxidant capacity and oxidative stress in patients with metabolic syndrome. Nutrition 24:675–681

    Article  PubMed  Google Scholar 

  • Simão ANC, Lozovoy MAB, Dichi I (2014) Oxidative stress in metabolic syndrome. In: Dichi I, Breganó JW, Simão ANC, Cecchini R (eds) Role of oxidative stress in chronic diseases, 1st edn. Group, CRC Press Taylor & Francis, Boca Raton, p 246, ISBN 9781482216813

    Chapter  Google Scholar 

  • Tuttolomondo A, Pecoraro R, Di Raimondo D et al (2014) Immune-inflammatory markers and arterial stiffness indexes in subjects with acute ischemic stroke with and without metabolic syndrome. Diabetol Metab Syndr 6:28

    Article  PubMed Central  PubMed  Google Scholar 

  • Uchino K, Billheimer D, Cramer SC (2001) Entry criteria and baseline characteristics predict outcome in acute stroke trials. Stroke 32:909–916

    Article  CAS  PubMed  Google Scholar 

  • Urakawa H, Katsuki A, Sumida Y et al (2003) Oxidative stress is associated with adiposity and insulin resistance in men. J Clin Endocrinol Metab 88:4673–4676

    Article  CAS  PubMed  Google Scholar 

  • Uyttenboogaart M, Stewart RE, Vroomen PC, De Keyser J, Luijckx GJ (2005) Optimizing cutoff scores for the Barthel index and the modified Rankin scale for defining outcome in acute stroke trials. Stroke 6:1984–1987

    Article  Google Scholar 

  • Van den Berg E, Biessels GJ, de Craen AJM et al (2007) The metabolic syndrome is associated with decelerated cognitive decline in the oldest old. Neurology 69:979–985

    Article  PubMed  Google Scholar 

  • Weaver CS, Leonardi-Bee J, Bath-Hextall FJ, Bath PMW (2004) Sample size calculations in acute stroke trials: a systematic review of their reporting characteristics, and relationship with outcome. Stroke 35:1216–1224

    Article  PubMed  Google Scholar 

  • Witko-Sarsat V, Friedlander M, Nguyen Khoa T et al (1998) Advanced oxidation protein products as novel mediators of inflammation and monocyte activation in chronic renal failure. J Immunol 161:2524–2532

    CAS  PubMed  Google Scholar 

  • Woodruff TM, Thundyil J, Tang S-C et al (2011) Pathophysiology, treatment, and animal and cellular models of human ischemic stroke. Mol Neurodegener 6:11

    Article  PubMed Central  PubMed  Google Scholar 

  • Yaffe K, Kanaya A, Lindquist K et al (2004) The metabolic syndrome, inflammation, and risk of cognitive decline. JAMA 292:2237–2242

    Article  CAS  PubMed  Google Scholar 

  • Zurawska-Plaksej E, Grzebyk E, Marciniak D et al (2014) Oxidatively modified forms of albumin in patients with risk factors of metabolic syndrome. J Endocrinol Investig 37(9):819–827

    Article  CAS  Google Scholar 

Download references

Conflict of interest

All the authors declare that there is no conflict of interest.

Author information

Authors and Affiliations

  1. Department Clinical of Pathology, Clinical Analysis and Toxicology, State University of Londrina, Robert Koch Avenue n° 60 Bairro Cervejaria, Londrina, Paraná, 86038-440, Brazil

    Andrea Name Colado Simão, Daniela Frizon Alfieri, Milena Zardetto Meloni, Tamires Flauzino, Bruna Miglioranza Scavuzzi, Marcell Alysson Batisti Lozovoy & Edna Maria Vissoci Reiche

  2. Department of Neurological Surgery, University of Londrina, Londrina, Paraná, Brazil

    Marcio Francisco Lehmann

  3. Department of Clinical Analysis, University North of Paraná (UNOPAR), Londrina, Paraná, Brazil

    Sayonara Rangel de Oliveira

  4. Department of Internal Medicine, University of Londrina, Londrina, Paraná, Brazil

    Isaias Dichi

Authors
  1. Andrea Name Colado Simão
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Marcio Francisco Lehmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Daniela Frizon Alfieri
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Milena Zardetto Meloni
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Tamires Flauzino
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Bruna Miglioranza Scavuzzi
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Sayonara Rangel de Oliveira
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Marcell Alysson Batisti Lozovoy
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Isaias Dichi
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Edna Maria Vissoci Reiche
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Andrea Name Colado Simão.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Simão, A.N.C., Lehmann, M.F., Alfieri, D.F. et al. Metabolic syndrome increases oxidative stress but does not influence disability and short-time outcome in acute ischemic stroke patients. Metab Brain Dis 30, 1409–1416 (2015). https://doi.org/10.1007/s11011-015-9720-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11011-015-9720-y

Keywords

Search

Navigation